| Rank | Ticker | Country | Price | Revenue | Analyst Rating | Analysts | IPO Year |
|---|---|---|---|---|---|---|---|
#1 | KRG | United States | $24.37 | $844,365,000.00 | Buy | 11 | 2004 |
#2 | INCY | United States | $92.90 | $3,394,635,000.00 | Buy | 21 | 1994 |
#3 | AA | United States | $58.52 | $12,831,000,000.00 | Buy | 11 | 2016 |
#4 | CDE | United States | $16.51 | $709,598,000.00 | Strong Buy | 5 | 1994 |
#5 | CSTM | France | $24.41 | $8,449,000,000.00 | Strong Buy | 4 | 2012 |
#6 | FAF | United States | $59.16 | $7,452,200,000.00 | Buy | 4 | 2009 |
#7 | TBPH | United States | $15.51 | $15,386,000.00 | Buy | 6 | 2013 |
#8 | CRDO | Cayman Islands | $97.78 | $436,775,000.00 | Strong Buy | 12 | 2022 |
#9 | IREN | Australia | $38.76 | $501,023,000.00 | Buy | 11 | 2021 |
#10 | PACS | United States | $32.39 | $5,288,932,000.00 | Strong Buy | 4 | 2024 |
#11 | VTR | United States | $82.73 | $5,833,980,000.00 | Buy | 13 | 2005 |
#12 | FRPT | United States | $58.80 | $1,102,015,000.00 | Buy | 17 | 2014 |
#13 | INSP | United States | $51.16 | $82,050,000.00 | Buy | 16 | 2018 |
#14 | LEVI | United States | $18.44 | $6,282,000,000.00 | Strong Buy | 13 | 2019 |
#15 | BHRB | United States | $61.40 | $0.00 | Strong Buy | 4 | 2023 |
#16 | AMRX | United States | $12.16 | $0.00 | Strong Buy | 4 | 2018 |
#17 | DIS | United States | $95.27 | $94,425,000,000.00 | Strong Buy | 16 | 2018 |
#18 | NTST | United States | $18.76 | $195,006,000.00 | Strong Buy | 13 | 2020 |
#19 | KROS | United States | $11.14 | $243,864,000.00 | Buy | 8 | 2020 |
#20 | CPT | United States | $98.11 | $12,967,000.00 | Buy | 17 | 1995 |
#21 | WLDN | United States | $81.40 | $273,352,000.00 | Strong Buy | 4 | 2006 |
#22 | RUN | United States | $12.84 | $858,578,000.00 | Buy | 20 | 2015 |
#23 | APLS | United States | $17.77 | $1,003,782,000.00 | Buy | 21 | 2015 |
#24 | CCI | United States | $77.51 | $4,264,000,000.00 | Buy | 15 | 1998 |
#25 | SLNO | United States | $31.00 | $1,450,788.00 | Strong Buy | 11 | 2014 |
#26 | WGO | United States | $32.02 | $1,985,674,000.00 | Buy | 11 | 1994 |
#27 | WBD | United States | $27.18 | $0.00 | Buy | 21 | 2008 |
#28 | ALHC | United States | $17.38 | $3,948,719,000.00 | Buy | 10 | 2021 |
#29 | DKNG | United States | $21.22 | $6,054,525,000.00 | Strong Buy | 30 | 2021 |
#30 | CTRE | United States | $37.40 | $476,393,000.00 | Buy | 9 | 2013 |
#31 | MEG | United States | $22.74 | $830,538,000.00 | Buy | 4 | 2020 |
#32 | STOK | United States | $32.83 | $184,420,000.00 | Strong Buy | 10 | 2019 |
#33 | ARQT | United States | $22.69 | $376,072,000.00 | Strong Buy | 6 | 2020 |
#34 | BEAM | United States | $23.73 | $24,000.00 | Buy | 13 | 2019 |
#35 | SMTC | United States | $77.54 | $1,049,975,000.00 | Strong Buy | 15 | 2000 |
#36 | MIRM | United States | $89.25 | $19,138,000.00 | Strong Buy | 12 | 2019 |
#37 | PECO | United States | $36.91 | $726,594,000.00 | Buy | 8 | 2010 |
#38 | MRCY | United States | $78.37 | $912,020,000.00 | Buy | 7 | 1997 |
#39 | AVTX | United States | $13.71 | $27,813,137.00 | Strong Buy | 6 | 2015 |
#40 | SHC | United States | $13.65 | $1,163,617,000.00 | Buy | 7 | 2020 |
#41 | PRVA | United States | $20.24 | $2,122,842,000.00 | Strong Buy | 14 | 2021 |
#42 | LASR | United States | $67.00 | $191,359,000.00 | Strong Buy | 8 | 2018 |
#43 | IDYA | United States | $31.80 | $218,710,000.00 | Strong Buy | 16 | 2019 |
#44 | AZTA | United States | $21.72 | $593,821,000.00 | Strong Buy | 5 | 1996 |
#45 | VCEL | United States | $30.92 | $276,259,000.00 | Strong Buy | 5 | 1996 |
#46 | TRU | United States | $68.73 | $4,576,300,000.00 | Buy | 11 | 2013 |
#47 | ARVN | United States | $10.98 | $262,600,000.00 | Buy | 20 | 2018 |
#48 | HCSG | United States | $19.29 | $1,837,173,000.00 | Buy | 6 | 1994 |
#49 | IMNM | United States | $20.65 | $6,941,000.00 | Strong Buy | 10 | 2020 |
#50 | CRVS | United States | $14.39 | $0.00 | Strong Buy | 5 | 2016 |
The FinQuota filters have identified what they believe to be the "Best Stocks Under $100 to Buy (March 26, 2026) | FinQuota" to buy now. However, please note that this information should not be considered as financial advice, as investing involves risks. We strongly recommend consulting with a qualified financial advisor before making any decisions regarding buying or selling stocks.